ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
MSD Merck Sharp & Dohme AG - Vaxneuvance, Injektionssuspension
6875201
VaxneuvanceInjektionssuspension
J07AL02Pneumococcus, Purified Polysaccharides Antigen Conjugated
14.02.2023  
Composition
polysaccharida streptococci pneumoniae typus 1 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 3 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 4 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 5 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 6A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 6B conjugata cum proteino corynebacteriae diphtheriae CRM 197 4 µg et polysaccharida streptococci pneumoniae typus 7F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 9V conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 14 conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 18C conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 19A conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 19F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 22F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 23F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg et polysaccharida streptococci pneumoniae typus 33F conjugata cum proteino corynebacteriae diphtheriae CRM 197 2 µg corresp. polysaccharida 32 µg et proteinum corynebacteriae diphtheriae CRM 197 ca. 30 µg, adjuvans: aluminium 0.125 mg ut aluminii phosphas, natrii chloridum corresp. natrium 1.77 mg, histidinum, polysorbatum 20, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml.
Packungsbestandteile
Injection suspension 
  
 
Active AgentDose
Polysaccharida Streptococci Pneumoniae Typus 18c Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 19a Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 19f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 22f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 23f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 33f Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml correspond Polysaccharida 32µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 6A Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 6B Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1974µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 7F Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
Polysaccharida Streptococci Pneumoniae Typus 9V Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml
BAG: Active Agent
Vaccinum Pneumococcale Polysaccharidicum crm Conjugatum 15-Valens
 
Inactive agentsDoseadditional_information
Alumine0.125mg / 0.5mladjuvans
Conjugata cum Proteino Corynebacteriae Diphtheriae crm 1972µg / 0.5ml 
Histidine  
Sodium Chloride  
Polysaccharida Streptococci Pneumoniae Typus14  
Polysorbatum 20  
Proteinum Corynebacteriae Diphtheriae crm 19730µg / 0.5ml 
 
Package numberPackage SizeEFPCPCategorySLOut of trade (MedRef)
001 58.2879.80BSLYes
00210582.80650.25BSLYes
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home